• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 5 of 100
TechAstraZeneca to buy cell therapy biotech for up to $1 billion
By Ashleigh Furlong and BloombergMarch 17, 2025
CommentaryMy son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup
By Michelle WernerMarch 10, 2025
Interest in GLP-1 medications like Ozempic will continue to grow given the multiple health conditions they can improve.
CommentaryThe crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up
By Wendy BarnesMarch 4, 2025
Anne Wojcicki on stage at a conference
LeadershipA few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million
By Lila MacLellanMarch 1, 2025
Emma Walmsley, chief executive officer of GlaxoSmithKline speaks during the Clinton Global Initiative annual meeting in New York City on September 24, 2024.
HealthGSK could double CEO Emma Walmsley’s pay to $27 million in bid to bring U.K. exec salaries in line with the U.S.
By Ryan HoggFebruary 28, 2025
Eli Lilly's headquarters sits behind a gate with the US flag raised
FinanceEli Lilly to spend $27 billion to bolster U.S. drug manufacturing as Trump tariffs loom
By Madison Muller and BloombergFebruary 26, 2025
LeadershipBayer CEO Bill Anderson on diversity initiatives, new menopause drugs and how to tame a runaway bureaucracy
By Fortune EditorsFebruary 26, 2025
Robert F. Kennedy Jr.
HealthWith RFK Jr. in charge, supplement makers see chance to cash in
By KFF Health News and Arthur AllenFebruary 25, 2025
Semaglutide medications Wegovy and Ozempic are pictured
HealthWegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
By Bloomberg, Madison Muller, Ike Swetlitz and Naomi KresgeFebruary 21, 2025
United States President Donald J. Trump speaks at the Friends of Ireland luncheon hosted by United States Speaker of the House of Representatives Paul Ryan, Republican of Wisconsin, at the United States Capitol March 15, 2018 in Washington, DC.
FinanceWeight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
By Ryan HoggFebruary 19, 2025
A woman holds a medicine bottle while reading instructions.
HealthGen Z’s expensive drug habit: More want brand-name meds that are 79% more expensive
By Lindsey LeakeFebruary 14, 2025
Hens at a poultry farm
HealthExperts sound the alarm as Ohio farmworker’s bird flu sparks fear it’s the next pandemic
By Lindsey LeakeFebruary 13, 2025
A woman injects herself with medication.
HealthOzempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’
By Lindsey LeakeFebruary 11, 2025
Cancer vaccination, conceptual illustration
HealthPersonalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
By Lindsey LeakeFebruary 7, 2025
A young woman undergoes a brain scan.
HealthMeet the 24-year-old helping Lilly test a preventive Alzheimer’s drug
By Lindsey LeakeFebruary 6, 2025
1...
  • 3
  • 4
  • 5
  • 6
  • 7
...100
Most Popular
Innovation
An MIT roboticist who cofounded bankrupt robot vacuum maker iRobot says Elon Musk’s vision of humanoid robot assistants is ‘pure fantasy thinking’An image of a popular article
By Marco Quiroz-GutierrezFebruary 25, 2026
Success
Jeff Bezos says being lazy, not working hard, is the root of anxiety: ‘The stress goes away the second I take that first step’An image of a popular article
By Sydney LakeFebruary 25, 2026
Commentary
'The Pitt': a masterclass display of DEI in action An image of a popular article
By Robert RabenFebruary 26, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.